Which versions of Web Based Pharmacy Product Management System are affected by CVE-2026-3401?

CVE-2026-3401 is a low-severity vulnerability in A weakness (CVSS 3.1). The limited severity suggests constrained impact, typically requiring specific conditions or local access for exploitation.

Is there a public PoC exploit available for CVE-2026-3401?

Yes, a public proof-of-concept exploit is available for CVE-2026-3401. Prioritise patching immediately. EPSS: 0.1%.

How to fix or mitigate CVE-2026-3401?

During next maintenance window: Apply vendor patches when convenient. Monitor vendor channels for updates.

Web Based Pharmacy Product Management System CVE-2026-3401

Q: What is the CVSS score of CVE-2026-3401?

CVE-2026-3401 has a CVSS 4.0 base score of 1.3 (Low). CVSS vector: CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X. EPSS exploitation probability: 0.1%.

LOW

Insufficient Session Expiration (CWE-613)

2026-03-02 cna@vuldb.com

Information Disclosure Web Based Pharmacy Product Management System

1.3

CVSS 4.0 · NVD

Severity by source

NVD PRIMARY

1.3 LOW

CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Attack Vector

Network

Attack Complexity

High

Privileges Required

Low

User Interaction

None

Scope

Lifecycle Timeline

CVSS changed

Apr 29, 2026 - 01:11 NVD

3.1 (LOW) 1.3 (LOW)

Analysis Generated

Mar 12, 2026 - 21:55 vuln.today

PoC Detected

Mar 03, 2026 - 19:47 vuln.today

Public exploit code

CVE Published

Mar 02, 2026 - 01:16 nvd

LOW 3.1

DescriptionCVE.org

A weakness has been identified in SourceCodester Web-based Pharmacy Product Management System 1.0. This affects an unknown part. This manipulation causes session expiration. Remote exploitation of the attack is possible. The complexity of an attack is rather high. It is indicated that the exploitability is difficult. The exploit has been made available to the public and could be used for attacks.

AnalysisAI

Web-Based Pharmacy Product Management System versions up to 1.0 is affected by insufficient session expiration (CVSS 3.1).

Unlock full vulnerability intelligence

Risk assessment & exploitation conditions
Attack chain visualization
Remediation with exact patch versions
Threat intelligence from 22 sources
Personal watchlist & email alerts

Continue with Google Continue with GitHub

Free forever · No credit card required

Vulnerability AssessmentAI

Risk Assessment	CVSS 3.1 (LOW). … Full risk analysis with EPSS, KEV, and SSVC signal comparison available after sign-in.
Exploit Scenario	A remote attacker could exploit this vulnerability to compromise the affected system.
Remediation	Monitor vendor advisories for a patch. … Detailed patch versions, workarounds, and compensating controls in full report.

Recommended ActionAI

During next maintenance window: Apply vendor patches when convenient. …

Threat intelligence, references, and detailed analysis are available after sign-in.

CVE-2026-3401 vulnerability details – vuln.today

Back